Pirfenidone reduced disease progression in idiopathic pulmonary fibrosis
- PMID: 25329221
- DOI: 10.7326/0003-4819-161-8-201410210-02004
Pirfenidone reduced disease progression in idiopathic pulmonary fibrosis
Comment on
-
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836312 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources